One study showed that engineering T cells to highly express CXCR6 made these T cells attracted to the CXC chemokine ligand 16 released by pancreatic cancer cells, resulting in enhanced T cell recognition and clearance of pancreatic cancer cells (175). Here, CXCL16 is linked to familial pancreatic carcinoma.